Positive correlation between serum liver enzyme levels and standard uptake values of liver on FDG-PET

Clinical Imaging

Volumn 34, Issue 2, 2010, Pages 109-112

  Lin, Chun Y ^a   Ding, Hueisch J ^b   Lin, Tsann ^c   Lin, Cheng C ^c   Kuo, Tsung H ^a   Kao, Chia H ^c  

^a SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

FDG PET; Serum liver enzyme; Standard uptake value

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CLINICAL MANIFESTATION; FDG-PET; FLUORO 2 DEOXY D GLUCOSE; HEALTH EXAMINATIONS; HEALTH SCREENINGS; HEALTHY SUBJECTS; MAXIMAL VALUES; POSITIVE CORRELATIONS; SERUM LIVER ENZYME; STANDARD UPTAKE VALUES; VIRUS INFECTION; WHOLE-BODY;

BODY FLUIDS; ENZYMES; GLUCOSE; POSITRON EMISSION TOMOGRAPHY; STANDARDS; VIRUSES;

LIVER;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; FLUORODEOXYGLUCOSE F 18;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC VALUE; DRUG UPTAKE; FALSE NEGATIVE RESULT; HEPATITIS B; HEPATITIS C; HUMAN; IMAGE ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; FEMALE; FLUORODEOXYGLUCOSE F18; HEPATITIS B ANTIBODIES; HEPATITIS C ANTIBODIES; HUMANS; LIVER; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 77049126008     PISSN: 08997071     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinimag.2009.05.007     Document Type: Article

References (25)

1. Rǎileanu I., Rusu V., Stefǎnescu C., Cinotti L., and Hountis D. 18F FDG PET-applications in oncology. Rev Med Chir Soc Med Nat Iasi 106 1 (2002) 14-23
2. Son H.B., Han C.J., Kim B.I., Kim J., Jeong S.H., Kim Y.C., Lee J.O., Choi C.Y., and Im S.M. Evaluation of various hepatic lesions with positron emission tomography. Taehan Kan Hakhoe Chi 8 4 (2002) 472-480
3. Gorospe L., Raman S., Echeveste J., Avril N., Herrero Y., and Herna Ndez S. Whole-body PET/CT: spectrum of physiological variants, artifacts and interpretative pitfalls in cancer patients. Nucl Med Commun 26 8 (2005) 671-687
4. Cook G.J. Pitfalls in PET/CT interpretation. Q J Nucl Med Mol Imaging 51 3 (2007) 235-243
5. Truong M.T., Pan T., and Erasmus J.J. Pitfalls in integrated CT-PET of the thorax: implications in oncologic imaging. J Thorac Imaging 21 2 (2006) lll-22
6. Cook G.J., Wegner E.A., and Fogelman I. Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging. Semin Nucl Med 34 2 (2004) 122-133
7. Kato T., Tsukamoto E., Suginami Y., Mabuchi M., Yoshinaga K., Takano A., Adachi I., Shiga T., Morita K., Katoh C., Kuge Y., and Tamaki N. Visualization of normal organs in whole-body FDG-PET imaging. Kaku Igaku 36 9 (1999) 971-977
8. Wong R.J. Current status of FDG-PET for head and neck cancer. J Surg Oncol 97 8 (2008) 649-652
9. Heusner T.A., Freudenberg L.S., Kuehl H., Hauth E.A., Veit-Haibach P., Forsting M., Bockisch A., and Antoch G. Whole-body PET/CT-mammography for staging breast cancer: initial results. Br J Radiol. 81 969 (2008) 743-748
10. Bouchelouche K., and Oehr P. Recent developments in urologic oncology: positron emission tomography molecular imaging. Curr Opin Oncol 20 3 (2008) 321-326
11. Roarke M.C., Nguyen B.D., and Pockaj B.A. Desmoplastic melanoma: true positive and false negative findings on F-18 FDG-PET/CT. Clin Nucl Med 33 8 (2008) 562-564
12. Mahmood S., and Martinez de Llano S.R. Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT. Clin Nucl Med 33 7 (2008) 510-512
13. Acar C., Akkas B.E., Sen I., Sozen S., and Kitapci M.T. False positive 18F-FDG PET scan in adrenal oncocytoma. Urol Int 80 4 (2008) 444-447
14. Dong M.J., Lin X.T., Zhao J., Guan Y.H., Zuo C.T., Chen X., Dai J.Z., and Jiang B.D. Malignant tumor with false negative 18F-FDG PET image. Zhonghua Zhong Liu Za Zhi 28 9 (2006) 713-717
15. Lin C.Y., Ding H.J., Liu C.S., Chen Y.K., Lin C.C., and Kao C.H. Correlation between the intensity of breast FDG uptake and menstrual cycle. Acad Radiol 14 8 (2007) 940-944
16. Meier J.M., Alavi A., Iruvuri S., Alzeair S., Parker R., Houseni M., Hernandez-Pampaloni M., Mong A., and Torigian D.A. Assessment of age-related changes in abdominal organ structure and function with computed tomography and positron emission tomography. Semin Nucl Med 37 3 (2007) 154-172
17. Eastman R.C., Carson R.E., Orloff D.G., Cochran C.S., Perdue J.F., Rechler M.M., Lanau F., Roberts C.T., Shapiro J., Roth J., et al. Glucose utilization in a patient with hepatoma and hypoglycemia. Assessment by a positron emission tomography. J Clin Invest 89 6 (1992) 1958-1963
18. Enomoto K., Fukunaga T., Okazumi S., Asano T., Kikuchi T., Yamamoto H., Nagashima T., Isono K., Itoh H., Imazeki K., et al. Can fluorodeoxyglucose-positron emission tomography evaluate the functional differentiation of hepatocellular carcinoma. Kaku Igaku 28 11 (1991) 1353-1356
19. Custer B., Sullivan S.D., Hazlet T.K., Iloeje U., Veenstra D.L., and Kowdley K.V. Global epidemiology of hepatitis B virus. J Clin Gastroenterol 38 10 Suppl 3 (2004) S158-S168
20. Lu J.N., and Chen C.J. Prevalence of hepatitis B surface antigen carrier status among residents in the endemic area of chronic arsenicism in Taiwan. Anticancer Res 11 1 (1991) 229-233
21. Craxì A., Laffi G., and Zignego A.L. Hepatitis C virus (HCV) infection: a systemic disease. Mol Aspects Med 29 1-2 (2008) 85-95
22. Sun C.A., Chen H.C., Lu C.F., You S.L., Mau Y.C., Ho M.S., Lin S.H., and Chen C.J. Transmission of hepatitis C virus in Taiwan: prevalence and risk factors based on a nationwide survey. J Med Virol 59 3 (1999) 290-296
23. Sahdev P., Garramone R.R., Schwartz R.J., Steelman S.R., and Jacobs L.M. Evaluation of liver function tests in screening for intra-abdominal injuries. Ann Emerg Med 20 8 (1991) 838-841
24. Giannini E., Risso D., Botta F., Chiarbonello B., Fasoli A., Malfatti F., Romagnoli P., Testa E., Ceppa P., and Testa R. Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. Arch Intern Med 163 2 (2003) 218-224
25. Giannini E., Botta F., Testa E., Romagnoli P., Polegato S., Malfatti F., Fumagalli A., Chiarbonello B., Risso D., and Testa R. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis. Am J Gastroenterol 97 11 (2002) 2855-2860